• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • Investors Relations
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
    • How to buy BIOMIMESYS®?
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Anti-Oxidant
      • Anti-Redness
      • Wound Healing
      • Skin Pigmentation
      • Anti-Pollution
      • Skin Microbiota
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications – Scientific articles
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificates of Analysis
    • TDS&MSDS
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us?
    • How to buy BIOMIMESYS®?
    • Subscribe to our Newsletter

automated microscope

Nanostem

Roberta’s secondment in HCS Pharma in the frame of Nanostem project

We were glad to welcome Roberta Bilardo for a 2 month-secondment in HCS Pharma in the frame of Nanostem project (Developing NANOmaterials for neural STEM cells drug delivery). She is working as a Marie Curie Fellow Early Stage Researcher in Prof Resmini’s research group at the School of Biological and Read more…

By Elodie Vandenhaute, 2 yearsJuly 20, 2021 ago
Biomimesys

Replay of our webinar about BIOMIMESYS Oncology for modelling cancer in 3D

Have you missed our last webinar with Molecular Devices about 3D oncology models? In April, our project leader Elodie was talking about how to establish and image physiologically relevant 3D cancer in vitro models, using BIOMIMESYS Oncology as a surrogate for the tumoral extracellular matrix. Our product BIOMIMESYS® Oncology matrix Read more…

By Elodie Vandenhaute, 2 yearsJune 22, 2021 ago
Biomimesys

Feedback from Molecular Devices’ User Meeting in Leiden

Just before Covid-19 pandemic crisis widely spread to France, we attended the User Meeting organized by Molecular Devices in Hilton Garden Inn Leiden (Oegstgeest, Netherlands). We enjoyed the programme, gathering a variety of topics but with high content analysis/screening as a common technique to answer diverse scientific questions. On the Read more…

By Elodie Vandenhaute, 3 yearsMarch 24, 2020 ago
News

We will attend HCS User Meeting by Molecular Devices in Leiden next week

We will give a presentation next week (on Tuesday, 10th of March 2020) at the High-Content Cellular Imaging User meeting organized by our partner Molecular Devices, which will take place in Leiden (Netherlands). It is a great pleasure for us to attend the meeting, and to talk about the applications, Read more…

By Elodie Vandenhaute, 3 yearsMarch 3, 2020 ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • Development of devices to study brain and liver metastasis of triple negative breast cancer cells
  • Advantages of 3D Cell Culture in Immuno-Oncology
  • First week of business trip in Asia for Nathalie Maubon (HCS Pharma)
  • Feedback from Molecular Devices’ User Meeting in Copenhagen
  • Meet Nathalie in Boston during BIO International Convention!
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell Cell Culture congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix genotoxicity HCS hcs pharma High content screening hyaluronic acid imaging innovation in vitro in vitro models liver meeting Microbiota microenvironment microscopy Molecular Devices NEUROCELL3D neurotoxicity ONCO3D oncology organoids Parkinson phenotypic screening picture screening skin toxicology webinar
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress
 

Loading Comments...